Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSMA PET”

391 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 391 results

Not applicableLooking for participantsNCT07474142
What this trial is testing

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

Who this might be right for
Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital 1,000
Very early researchUnknownNCT02691169
What this trial is testing

Integrated 18F-labelled PSMA Project

Who this might be right for
Prostate Cancer
St. Joseph's Healthcare Hamilton 10
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Very early researchUnknownNCT05955677
What this trial is testing

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 100
Testing effectiveness (Phase 2)Study completedNCT05407311
What this trial is testing

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Clarity Pharmaceuticals Ltd 53
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Not applicableLooking for participantsNCT06508567
What this trial is testing

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

Who this might be right for
Prostate Cancer RecurrentProstate Cancer
University Health Network, Toronto 20
Not applicableUnknownNCT04124107
What this trial is testing

Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection

Who this might be right for
Prostate Neoplasm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Not applicableNot Yet RecruitingNCT07709403
What this trial is testing

Radioactive Counts From PSMA PET/CT-Targeted Biopsy Specimens for Real-time Diagnosis of Prostate Cancer: A Prospective Study

Who this might be right for
Prostate Cancer
Peking University First Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT04461509
What this trial is testing

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleUrogenital Neoplasms+4 more
Alessandro D'Agnolo 62
Not applicableLooking for participantsNCT07707232
What this trial is testing

Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Wenzhou Medical University 4,600
Not applicableLooking for participantsNCT07580196
What this trial is testing

Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)

Who this might be right for
Prostate Cancer
University of Turin, Italy 820
Testing effectiveness (Phase 2)Study completedNCT06907641
What this trial is testing

Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy

Who this might be right for
Prostate Cancer (Post Prostatectomy)
St Vincent's Hospital, Sydney 50
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Testing effectiveness (Phase 2)Study completedNCT05613842
What this trial is testing

Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)

Who this might be right for
Prostate Cancer
St Vincent's Hospital, Sydney 30
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Not applicableLooking for participantsNCT06450548
What this trial is testing

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

Who this might be right for
Prostate Cancer Metastatic
Centre Henri Becquerel 60
Not applicableUnknownNCT06054789
What this trial is testing

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Who this might be right for
Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 8
Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Next Page